(0.38%) 5 037.26 points
(0.44%) 38 068 points
(0.73%) 15 719 points
(-0.28%) $78.78
(4.76%) $2.02
(0.04%) $2 311.90
(0.24%) $26.81
(0.73%) $961.90
(0.14%) $0.934
(0.06%) $11.04
(0.18%) $0.800
(-1.37%) $91.98
Quarter results today
(bmo 2024-05-02)
Expected move: +/- 8.49%
0.07% $ 57.76
@ $58.15
Wydano: 14 vas. 2024 @ 22:11
Zwrot: -0.67%
Poprzedni sygnał: vas. 13 - 16:30
Poprzedni sygnał:
Zwrot: 4.68 %
Live Chart Being Loaded With Signals
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need...
Stats | |
---|---|
Dzisiejszy wolumen | 77 807.00 |
Średni wolumen | 361 314 |
Kapitalizacja rynkowa | 2.08B |
EPS | $-1.340 ( 2024-03-01 ) |
Następna data zysków | ( $-1.350 ) 2024-05-30 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -11.11 |
ATR14 | $0.133 (0.23%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-23 | Seehra Jasbir | Buy | 125 000 | Employee Stock Option (right to buy) |
2024-02-13 | Seehra Jasbir | Buy | 125 000 | Employee Stock Option (right to buy) |
2024-02-13 | Regnante Keith | Buy | 40 000 | Employee Stock Option (right to buy) |
2024-02-13 | Rovaldi Christopher | Buy | 150 000 | Employee Stock Option (right to buy) |
2024-02-13 | Cooper Simon Peter | Buy | 40 000 | Employee Stock Option (right to buy) |
INSIDER POWER |
---|
67.74 |
Last 96 transactions |
Buy: 1 546 013 | Sell: 365 314 |
Wolumen Korelacja
Keros Therapeutics Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
PRAX | 0.919 |
CDNA | 0.904 |
HNNA | 0.894 |
RPAY | 0.889 |
TTEC | 0.888 |
EWTX | 0.883 |
SMSI | 0.882 |
SRAX | 0.879 |
ANNX | 0.876 |
LPCN | 0.874 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Keros Therapeutics Inc Korelacja - Waluta/Towar
Keros Therapeutics Inc Finanse
Annual | 2023 |
Przychody: | $151 000 |
Zysk brutto: | $-664 000 (-439.74 %) |
EPS: | $-5.20 |
FY | 2023 |
Przychody: | $151 000 |
Zysk brutto: | $-664 000 (-439.74 %) |
EPS: | $-5.20 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-1.62M (0.00 %) |
EPS: | $-4.15 |
FY | 2021 |
Przychody: | $20.10M |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-2.52 |
Financial Reports:
No articles found.
Keros Therapeutics Inc
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia in patients with myelodysplastic syndromes, and in patients with myelofibrosis. It is also developing small molecule product candidate KER-047 that is being developed for the treatment of anemia, and is currently in Phase 1 clinical trial; and KER-012, which is in Phase 1 clinical trial to treat disorders associated with bone loss, such as osteoporosis and osteogenesis imperfecta, and for the treatment of pulmonary arterial hypertension. The company was incorporated in 2015 and is headquartered in Lexington, Massachusetts.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej